Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genfit S.A. ADR (GNFT)

Genfit S.A. ADR (GNFT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 595,870
  • Shares Outstanding, K 37,833
  • Annual Sales, $ 8,850 K
  • Annual Income, $ -93,910 K
  • 60-Month Beta N/A
  • Price/Sales 66.90
  • Price/Cash Flow N/A
  • Price/Book 5.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.81
  • Number of Estimates 1
  • High Estimate -0.81
  • Low Estimate -0.81
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.13 +11.46%
on 11/25/19
17.18 -8.32%
on 11/11/19
+1.24 (+8.55%)
since 11/06/19
3-Month
13.21 +19.23%
on 10/08/19
18.00 -12.50%
on 09/16/19
-1.21 (-7.13%)
since 09/06/19

Most Recent Stories

More News
Intercept (ICPT) Q1 Earnings Miss Estimates, Revenues Beat

Intercept's (ICPT) Q1 revenues top estimates on strong Ocaliva sales, driven by sales force expansion.

MRK : 88.85 (+0.11%)
ICPT : 107.48 (-10.27%)
GILD : 67.08 (+1.74%)
GNFT : 15.75 (+0.64%)
Zacks.com featured highlights include: Teledyne, Genfit, Shoe Carnival, ZTO and GCI

Zacks.com featured highlights include: Teledyne, Genfit, Shoe Carnival, ZTO and GCI

ZTO : 20.92 (+0.53%)
TDY : 347.29 (+0.60%)
SCVL : 37.63 (+3.21%)
GLIBA : 69.88 (-0.01%)
GNFT : 15.75 (+0.64%)
Gilead to Collaborate with Novo Nordisk for NASH Treatment

Gilead Sciences (GILD) will collaborate with Novo Nordisk to develop treatments for liver disease, NASH.

NVO : 56.74 (-0.58%)
GILD : 67.08 (+1.74%)
ICPT : 107.48 (-10.27%)
GNFT : 15.75 (+0.64%)
Nasdaq Welcomes GENFIT S.A. (Nasdaq: GNFT) to The Nasdaq Stock Market

GENFIT S.A. (Nasdaq: GNFT), a late-stage clinical biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting liver diseases, in particular those...

GNFTF : 16.0000 (+0.50%)
GNFT : 15.75 (+0.64%)
NDAQ : 105.23 (+0.54%)
Trade GNFT with:

Business Summary

Genfit SA is a biopharmaceutical company. It focuses on the discovery and development of therapeutic and diagnostic solutions in metabolic and liver related diseases. The company's lead products include Elafibranor, Nitazoxanide and TGFTX1 which are in clinical stage. Genfit SA is based in Loos, France....

See More

Key Turning Points

2nd Resistance Point 16.21
1st Resistance Point 15.98
Last Price 15.75
1st Support Level 15.59
2nd Support Level 15.42

See More

52-Week High 26.25
Fibonacci 61.8% 21.27
Fibonacci 50% 19.73
Fibonacci 38.2% 18.19
Last Price 15.75
52-Week Low 13.21

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar